Search
forProducts matching "female"
Tracking 3 products like 151 Tugain 5 Solution (Minoxidil 5%), 152 Tugain 10 Solution (Minoxidil 10%) and 152 Tugain 10 Solution (Minoxidil 10%) from by companies like Inhouse Pharmacy and Realiable Pharmacy. View all 3 products »
Sort by
Research
780-810 / 1000+ resultsresearch Female Hair Loss: Low-Level Laser Therapy Effective for Female Pattern Hair Loss
Low-level laser therapy is safe and effective for treating female hair loss.
research Hair's the Question: Female Pattern Hair Loss
Early diagnosis and personalized treatment are crucial for managing Female Pattern Hair Loss in women.
research Evaluation of Androgen Receptor Gene as a Candidate Gene in Female Androgenetic Alopecia
The androgen receptor gene doesn't help identify women likely to have female pattern hair loss.
research Trichoscopic Criteria of Female Pattern Hair Loss
Female hair loss can be diagnosed using specific trichoscopy criteria.
research Hair Sciences: An Interview with Dr. Rodney Sinclair on Female Pattern Hair Loss
Dr. Rodney Sinclair uses a detailed grading system to diagnose female pattern hair loss, recommends daily spironolactone and minoxidil for treatment, and believes genetics play a role in the condition.
research Systemic Cyproterone Acetate and 5% Minoxidil Topical in the Treatment of Female Pattern Hair Loss
Systemic cyproterone acetate and 5% topical minoxidil are effective and safe for treating female pattern hair loss.
research Clinical Observation of Yifa Compound Treating 40 Cases of Female Pattern Hair Loss and Its Effect on Serum Dihydrotestosterone and Dehydroepiandrosterone
Yifa compound effectively treats female pattern hair loss and lowers DHT and DHEA levels.
research Female Pattern Hair Loss: Current Treatment Concepts
Female pattern hair loss, common in women, can be treated with oral antiandrogens and topical minoxidil, but these are more effective at preventing further loss than regrowing hair. Other helpful methods include counseling, cosmetic camouflage, and hair transplantation. Treatment must continue for effects to last and it may take up to 2 years to see results.
research Corrections to 'Female Pattern Hair Loss and Its Relationship to Permanent/Cicatricial Alopecia: A New Perspective'
Title change to "Central Centrifugal Cicatricial Alopecia (CCCA)"; common in African American women; hair-grooming methods may contribute; no effective therapy found; trials needed.
research Finasteride Treatment of Female Pattern Hair Loss
Finasteride with oral contraceptive improves hair loss in 62% of premenopausal women.
research Faculty Opinions Recommendation of Finasteride Treatment of Female Pattern Hair Loss
Oral finasteride, combined with drospirenone, improved hair loss in 62% of premenopausal women, with no reported side effects.
research Androgenetic Alopecia in Men and Women
Androgenetic alopecia causes distressing hair loss in aging men and women.
research Genetic Markers of Male and Female Pattern Hair Loss
Genetic differences in hair loss can help improve diagnosis and treatment.
research The Effect of Herbal Extract on Hair Growth in Female Androgenetic Alopecia
Herbal extract improves hair growth in female pattern baldness.
research Antiandrogen Therapy for Female-Pattern Hair Loss
Antiandrogens like spironolactone can help treat female-pattern hair loss.
research Female Pattern Hair Loss: A Review
Female pattern hair loss in women is caused by hormones and genetics, leading to hair thinning, with various treatments available.
research Female Pattern Hair Loss
Female pattern hair loss affects crown, increases with age, and has limited treatments.
research Hair Density, Hair Diameter, And The Prevalence Of Female Pattern Hair Loss: Reply From Authors
Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.
research Antiandrogens in Female Androgenetic Alopecia
Antiandrogens can help treat female pattern hair loss.
research Serum Prostate Specific Antigen Levels in Women with Androgenetic Alopecia
Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.
research Blood Pressure Levels in Women with Androgenetic Alopecia
Women with androgenetic alopecia may have higher blood pressure levels.
research Psychological Characteristics of Alopecia Areata and Androgenetic Alopecia in Women
Women with alopecia often experience high levels of anxiety and depression, needing psychiatric help.
research Analysis of Steroids and Binding Proteins in the Blood of Women with Androgenetic Alopecia
Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.
research Knowledge About Androgenetic Alopecia Among Women and Men – A Survey Research
Women know more about androgenetic alopecia than men.
research Relationship Between Androgenetic Alopecia and Cardiovascular Comorbidity Markers in Women
Women with hair loss may have higher heart disease risk.
research Clinical and Epidemiological Characteristics and Condition of the Hormonal Status in Women with Androgenetic Alopecia
Women with androgenetic alopecia often have other symptoms of high androgen levels, requiring further hormone testing.
research Distribution of Copper, Manganese, Selenium, and Zinc in Occipital and Frontal Hair Zones and Hormonal Profiles in Women with Androgenetic Alopecia
Women with a certain type of hair loss have more copper in the back of their head than the front, and treatment can normalize hair but not copper levels.
research Androgen Excess in Women: Experience with Over 1000 Consecutive Patients
Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.
research 2014 Female Athlete Triad Coalition Consensus Statement on Treatment and Return to Play of the Female Athlete Triad: 1st International Conference Held in San Francisco, California, May 2012 and 2nd International Conference Held in Indianapolis, Indiana, May 2013
The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.